Craft

Primrose Therapeutics

Total Funding

$752.6 K

Primrose Therapeutics Summary

Company Summary

Overview
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. PKD is one of the most common life-threatening genetic disorders which results in the abnormal growth of cells in the kidney, that eventually lead to the development of bilateral kidney cysts and structural destruction of the kidney.
Type
Private
Status
Closed
HQ
New York, NY, US | view all locations
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • New York, NY HQ

    United States

    875 3rd Ave #3rd

Footer menu